Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Teriparatide

EU orphan designation number: EU/3/16/1689   
Active ingredient: Teriparatide
Indication: Treatment of hypoparathyroidism
Sponsor: Boyd Consultants Limited
Dublin City University, DCU Invent, Glasnevin, Dublin 9, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2016 Orphan designation EMA/OD/031/16 (2016)4130 of 27/06/2016
22/10/2018 Transfer of orphan designation EMA/OD/031/16/T/01 (2018)6987 of 18/10/2018
27/03/2019 Transfer of orphan designation EMA/OD/0000004935 (2019)2384 of 25/03/2019